PERSPECTA

News from every angle

← Back to headlines

Canaccord Maintains Buy Rating on Compass Therapeutics (CMPX)

Canaccord has reiterated its Buy rating for Compass Therapeutics (CMPX).

5 May, 12:16 — 5 May, 12:16
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual7d ago

Canaccord Maintains Buy Rating on Compass Therapeutics (CMPX)

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Pangasinan Town to Clear Rivers of Fish Pens

just now

Caraga cops eye big syndicates in P3-B illegal cigarette shipment

just now

Nigerian President Tinubu Hails France-Nigeria Business Council Meeting

just now